S. 2993 — Drug Competition Act of 2000

Summary

Drug Competition Act of 2000 - Requires brand name drug manufacturers and generic drug manufacturers to file with the Federal Trade Commission and the Attorney General agreements affecting the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product.

Full Text

Legislative Actions

2000-07-27
Introduced in Senate
2000-07-27
Sponsor introductory remarks on measure. (CR S7907-7908)
2000-07-27
Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S7908-7909)

Drug Competition Act of 2000

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill